I think they should wait to announce the launch of LYmpro get the share price to at least .50 .60 cents then uplist. As it stands now at .07 per share they would have to do a 1 for 75 reverse split to get to around $5.25 per share.
I think it is best to wait to see all catalysts before Lympro Launch and then Lympro Launch itself before thinking of uplisting. That is of course if the price goes up on its own to .50 cents per share then even better.